SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-16-764470
Filing Date
2016-11-09
Accepted
2016-11-09 16:51:53
Documents
59
Period of Report
2016-09-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q d281461d10q.htm 10-Q 540305
2 EX-10.1 d281461dex101.htm EX-10.1 52942
3 EX-31.1 d281461dex311.htm EX-31.1 6051
4 EX-31.2 d281461dex312.htm EX-31.2 6047
5 EX-32.1 d281461dex321.htm EX-32.1 6510
  Complete submission text file 0001193125-16-764470.txt   3213921

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT cfrx-20160930.xml EX-101.INS 498251
7 XBRL TAXONOMY EXTENSION SCHEMA cfrx-20160930.xsd EX-101.SCH 40332
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE cfrx-20160930_cal.xml EX-101.CAL 48272
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE cfrx-20160930_def.xml EX-101.DEF 135119
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE cfrx-20160930_lab.xml EX-101.LAB 326147
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE cfrx-20160930_pre.xml EX-101.PRE 237588
Mailing Address 28 WELLS AVENUE 3RD FLOOR YONKERS NY 10701
Business Address 28 WELLS AVENUE 3RD FLOOR YONKERS NY 10701 914-207-2300
CONTRAFECT Corp (Filer) CIK: 0001478069 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36577 | Film No.: 161984909
SIC: 2834 Pharmaceutical Preparations